{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T23:26:03Z","timestamp":1777937163386,"version":"3.51.4"},"reference-count":8,"publisher":"SAGE Publications","issue":"13","license":[{"start":{"date-parts":[[2018,10,11]],"date-time":"2018-10-11T00:00:00Z","timestamp":1539216000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["Mult Scler"],"published-print":{"date-parts":[[2018,11]]},"abstract":"<jats:p>Despite proven efficacy of alemtuzumab in multiple sclerosis (MS), approximately 50% of individuals will develop a new autoimmune disease following treatment. To date, these have largely been antibody mediated and organ specific (primarily affecting the thyroid gland). In a retrospective case series of 187 patients from two UK specialist centres (Cardiff and Cambridge) followed up for a median of 10\u2009years, we report three (1.6%) cases of sarcoidosis following alemtuzumab treatment of MS. This report increases the spectrum of auto-inflammatory disease following alemtuzumab and should be considered by clinicians when using this therapeutic agent for MS.<\/jats:p>","DOI":"10.1177\/1352458518790391","type":"journal-article","created":{"date-parts":[[2018,10,11]],"date-time":"2018-10-11T10:20:01Z","timestamp":1539253201000},"page":"1779-1782","update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":28,"title":["Sarcoidosis following alemtuzumab treatment for multiple sclerosis"],"prefix":"10.1177","volume":"24","author":[{"given":"Mark D","family":"Willis","sequence":"first","affiliation":[{"name":"Institute of Psychological Medicine and Clinical Neuroscience, Cardiff University and University Hospital of Wales, Cardiff, UK; Department of Neurology, University Hospital of Wales, Cardiff, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ben","family":"Hope-Gill","sequence":"additional","affiliation":[{"name":"Department of Respiratory Medicine, University Hospital Llandough, Llandough, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patrick","family":"Flood-Page","sequence":"additional","affiliation":[{"name":"Department of Respiratory Medicine, Royal Gwent Hospital, Newport, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fady","family":"Joseph","sequence":"additional","affiliation":[{"name":"Department of Neurology, Royal Gwent Hospital, Newport, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ed","family":"Needham","sequence":"additional","affiliation":[{"name":"Department of Neurology, Addenbrooke\u2019s Hospital, Cambridge, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joanne","family":"Jones","sequence":"additional","affiliation":[{"name":"Department of Neurology, Addenbrooke\u2019s Hospital, Cambridge, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alasdair","family":"Coles","sequence":"additional","affiliation":[{"name":"Department of Neurology, Addenbrooke\u2019s Hospital, Cambridge, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Neil P","family":"Robertson","sequence":"additional","affiliation":[{"name":"Institute of Psychological Medicine and Clinical Neuroscience, Cardiff University and University Hospital of Wales, Cardiff, UK; Department of Neurology, University Hospital of Wales, Cardiff, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"179","published-online":{"date-parts":[[2018,10,11]]},"reference":[{"key":"bibr1-1352458518790391","doi-asserted-by":"publisher","DOI":"10.1007\/s11910-016-0685-y"},{"key":"bibr2-1352458518790391","doi-asserted-by":"publisher","DOI":"10.1055\/s-0033-1343797"},{"key":"bibr3-1352458518790391","doi-asserted-by":"publisher","DOI":"10.1177\/1352458515614092"},{"key":"bibr4-1352458518790391","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000005420"},{"key":"bibr5-1352458518790391","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(13)60680-7"},{"key":"bibr6-1352458518790391","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.2007.06687.x"},{"key":"bibr7-1352458518790391","doi-asserted-by":"publisher","DOI":"10.1016\/S1413-8670(11)70259-8"},{"key":"bibr8-1352458518790391","doi-asserted-by":"publisher","DOI":"10.1212\/NXI.0000000000000034"}],"container-title":["Multiple Sclerosis Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/1352458518790391","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1177\/1352458518790391","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/1352458518790391","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,2]],"date-time":"2026-05-02T03:55:25Z","timestamp":1777694125000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1177\/1352458518790391"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,10,11]]},"references-count":8,"journal-issue":{"issue":"13","published-print":{"date-parts":[[2018,11]]}},"alternative-id":["10.1177\/1352458518790391"],"URL":"https:\/\/doi.org\/10.1177\/1352458518790391","relation":{},"ISSN":["1352-4585","1477-0970"],"issn-type":[{"value":"1352-4585","type":"print"},{"value":"1477-0970","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,10,11]]}}}